Alicaforsen sodium

N/A

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameAlicaforsen sodium
Drug Alias NamealicaforsenCamligoAP-1431ISIS-2302AP-1451 +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionIntercellular adhesion molecule-1 inhibitorsImmunosuppressants
TargetsIntercellular adhesion molecule-1
Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel DiseasesPouchitis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[14] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals IncAtlantic Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals Inc
Inactive CompaniesAtlantic Pharmaceuticals Ltd
Active IndicationsPouchitis
Inactive IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksWikipedia